Tag: CVS Health Corp

Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison

FDA approves Eli Lilly’s GLP-1 pill, opening the next phase of the weight loss drug market

Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly

The price of menstrual products is skyrocketing from inflation, tariffs

9% of ACA health-care plan enrollees go uninsured after enhanced subsidies expire, poll finds

Healthy Returns: Stopping GLP-1s raises risk of heart attack, stroke and death, study says

Eli Lilly launches program to help boost employer coverage of obesity drugs in U.S.

Why Novo Nordisk’s Ireland expansion is key to fighting off Eli Lilly

Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients

Eli Lilly launches new form of obesity drug Zepbound with a month’s worth of doses in one pen